Search

everythinglearnresearchcommunity

for

Search:↓

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Some common medications can harm male fertility, but many effects can be reversed.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Advanced human skin models improve drug development and could replace animal testing.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Wound healing insights can improve regenerative medicine.

Human skin cells can be turned into versatile stem cells, but their ability to do so decreases with repeated use.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Recognizing oral symptoms can help diagnose and treat blood and nutritional diseases early.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

The study found that combining different databases gives a better estimate of drug side effects in hospitals.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Immune cells affect hair growth and could lead to new hair loss treatments.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.